TGFB1-induced extracellular expression of TGFBIP and inhibition of TGFBIP expression by RNA interference in a human corneal epithelial cell line

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 2, 2011, Pages 757-763

  Yellore, Vivek S ^a   Rayner, Sylvia A ^a   Aldave, Anthony J ^a  

^a JULES STEIN EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; MESSENGER RNA; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA INDUCED PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; BETAIG H3 PROTEIN; BETAIG-H3 PROTEIN; SCLEROPROTEIN; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL LEVEL; CELL LINE; CONTROLLED STUDY; CORNEA DYSTROPHY; CORNEA EPITHELIUM; DRUG MECHANISM; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; RNA INTERFERENCE; CELL FREE SYSTEM; DRUG ANTAGONISM; DRUG EFFECT; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE; CELL-FREE SYSTEM; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIUM, CORNEAL; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOENZYME TECHNIQUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79953287501     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5362     Document Type: Article

References (45)

1. Brady SE, Rapuano CJ, Arentsen JJ, Cohen EJ, Laibson PR. Clinical indications for and procedures associated with penetrating kera-toplasty. 1983-1988. Am J Ophthalmol. 1989;108(2):118-122.
2. Cosar CB, Sridhar MS, Cohen EJ, et al. Indications for penetrating keratoplasty and associated procedures: 1996-2000. Cornea. 2002;21(2):148-151.
3. Dobbins KR, Price FW, Whitson WE. Trends in the indications for penetrating keratoplasty in the midwestern United States. Cornea. 2000;19(6):813-816.
4. Lois N, Kowal VO, Cohen EJ, et al. Indications for penetrating keratoplasty and associated procedures: 1989-1995. Cornea. 1997;16(6):623-629.
5. Aldave AJ, Sonmez B. Elucidating the molecular genetic basis of the corneal dystrophies: are we there yet? Arch Ophthalmol. 2007; 125(2):177-186.
6. Konishi M, Yamada M, Nakamura Y, Mashima Y. Immunohistology of kerato-epithelin in corneal stromal dystrophies associated with R124 mutations of the BIGH3 gene. Curr Eye Res. 2000;21(5):891-896.
7. Korvatska E, Munier FL, Chaubert P, et al. On the role of kerato-epithelin in the pathogenesis of 5q31-linked corneal dystrophies. Invest Ophthalmol Vis Sci. 1999;40(10):2213-2219.
8. Dinh R, Rapuano CJ, Cohen EJ, Laibson PR. Recurrence of corneal dystrophy after excimer laser phototherapeutic keratectomy. Ophthalmology. 1999;106(8):1490-1497.
9. Inoue T, Watanabe H, Yamamoto S, et al. Recurrence of corneal dystrophy resulting from an R124H Big-h3 mutation after photo-therapeutic keratectomy. Cornea. 2002;21(6):570-573.
10. Marcon AS, Cohen EJ, Rapuano CJ, Laibson PR. Recurrence of corneal stromal dystrophies after penetrating keratoplasty. Cornea. 2003;22(1):19-21.
11. Lyons CJ, McCartney AC, Kirkness CM, Ficker LA, Steele AD, Rice NS. Granular corneal dystrophy: visual results and pattern of recurrence after lamellar or penetrating keratoplasty. Ophthalmology. 1994;101(11):1812-1817.
12. Meisler DM, Fine M. Recurrence of the clinical signs of lattice corneal dystrophy (type I) in corneal transplants. Am J Ophthal-mol. 1984;97(2):210-214.
13. Sorour HM, Yee SB, Peterson NJ, et al. Recurrence of chromosome 10 Thiel-Behnke corneal dystrophy (CDB2) after excimer laser phototherapeutic keratectomy or penetrating keratoplasty. Cornea. 2005;24(1):45-50.
14. Dogru M, Katakami C, Nishida T, Yamanaka A. Alteration of the ocular surface with recurrence of granular/avellino corneal dystrophy after phototherapeutic keratectomy: report of five cases and literature review. Ophthalmology. 2001;108(4):810-817.
15. Ellies P, Bejjani RA, Bourges JL, Boelle PY, Renard G, Dighiero P. Phototherapeutic keratectomy for BIGH3-linked corneal dystrophy recurring after penetrating keratoplasty. Ophthalmology. 2003; 110(6):1119-1125.
16. Orndahl MJ, Fagerholm PP. Treatment of corneal dystrophies with phototherapeutic keratectomy. J Refract Surg. 1998;14(2):129-135.
17. Aldave AJ, Yellore VS, Sonmez B, et al. A novel variant of combined granular-lattice corneal dystrophy associated with the Met619Lys mutation in the TGFBI gene. Arch Ophthalmol. 2008;126(3):371-377.
18. Kawasaki S, Nishida K, Quantock AJ, Dota A, Bennett K, Kinoshita S. Amyloid and Pro501 Thr-mutated (beta)ig-h3 gene product co-localize in lattice corneal dystrophy type IIIA. Am J Ophthalmol. 1999;127(4):456-458.
19. Klintworth GK, Valnickova Z, Enghild JJ. Accumulation of beta ig-h3 gene product in corneas with granular dystrophy. Am J Pathol. 1998;152(3):743-748.
20. Streeten BW, Qi Y, Klintworth GK, Eagle RC, Strauss JA, Bennett K. Immunolocalization of beta ig-h3 protein in 5q31-linked corneal dystrophies and normal corneas. Arch Ophthalmol. 1999;117(1): 67-75.
21. El Kochairi I, Letovanec I, Uffer S, Munier FL, Chaubert P, Schor-deret DF. Systemic investigation of keratoepithelin deposits in TGFBI/BIGH3-related corneal dystrophy. Mol Vis. 2006;12:461-466.
22. Akhtar S, Meek KM, Ridgway AE, Bonshek RE, Bron AJ. Deposits and proteoglycan changes in primary and recurrent granular dystrophy of the cornea. Arch Ophthalmol. 1999;117(3):310-321.
23. Aldave AJ, Sonmez B, Forstot SL, Rayner SA, Yellore VS, Glasgow BJ. A clinical and histopathologic examination of accelerated TGFBIp deposition after LASIK in combined granular-lattice corneal dystrophy. Am J Ophthalmol. 2007;143(3):416-419.
24. Jun RM, Tchah H, Kim TI, et al. Avellino corneal dystrophy after LASIK. Ophthalmology. 2004;111(3):463-468.
25. Kim TI, Roh MI, Grossniklaus HE, et al. Deposits of transforming growth factor-beta-induced protein in granular corneal dystrophy type II after LASIK. Cornea. 2008;27(1):28-32.
26. Kim TI, Kim T, Kim SW, Kim EK. Comparison of corneal deposits after LASIK and PRK in eyes with granular corneal dystrophy type II. J Refract Surg. 2008;24(4):392-395.
27. Wan XH, Lee HC, Stulting RD, et al. Exacerbation of Avellino corneal dystrophy after laser in situ keratomileusis. Cornea. 2002; 21(2):223-226.
28. Banning CS, Kim WC, Randleman JB, Kim EK, Stulting RD. Exacerbation of Avellino corneal dystrophy after LASIK in North America. Cornea. 2006;25(4):482-484.
29. Singh N, Higgins E, Amin S, et al. Unique homologous siRNA blocks hypoxia-induced VEGF upregulation in human corneal cells and inhibits and regresses murine corneal neovascularization. Cornea. 2007;26(1):65-72.
30. Cordeiro MF, Mead A, Ali RR, et al. Novel antisense oligonucleo-tides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome. Gene Ther. 2003;10(1):59-71.
31. Nakamura H, Siddiqui SS, Shen X, et al. RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosis. Mol Vis. 2004;10:703-711.
32. Yuan C, Zins EJ, Clark AF, Huang AJ. Suppression of keratoepithe-lin and myocilin by small interfering RNAs (siRNA) in vitro. Mol Vis. 2007;13:2083-2095.
33. Pfaffl MW, Georgieva TM, Georgiev IP, Ontsouka E, Hageleit M, Blum JW. Real-time RT-PCR quantification of insulin-like growth factor (IGF)-1, IGF-1 receptor, IGF-2, IGF-2 receptor, insulin receptor, growth hormone receptor, IGF-binding proteins 1, 2 and 3 in the bovine species. Domest Anim Endocrinol. 2002;22(2):91-102.
34. Couzin J. Molecular biology. RNAi shows cracks in its armor. Science. 2004;306(5699):1124-1125.
35. Jackson AL, Bartz SR, Schelter J, et al. Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol. 2003;21(6): 635-637.
36. Kannabiran C, Sridhar MS, Chakravarthi SK, Vemuganti GK, Lak-shmipathi M. Genotype-phenotype correlation in 2 Indian families with severe granular corneal dystrophy. Arch Ophthalmol. 2005; 123(8):1127-1133.
37. Moon JW, Kim SW, Kim TI, Cristol SM, Chung ES, Kim EK. Homozygous granular corneal dystrophy type II (Avellino corneal dystrophy): natural history and progression after treatment. Cornea. 2007;26(9):1095-1100.
38. Zou J, Chu RY, Zhou XT, Dai JH. [The effects on corneal wound healing of LASIK with ultra-thin corneal flaps and LASEK in rabbits]. Zhonghua Yan Ke Za Zhi. 2009;45(7):594-600.
39. Ivarsen A, Laurberg T, Moller-Pedersen T. Role of keratocyte loss on corneal wound repair after LASIK. Invest Ophthalmol Vis Sci. 2004;45(10):3499-3506.
40. Kaji Y, Soya K, Amano S, Oshika T, Yamashita H. Relation between corneal haze and transforming growth factor-beta1 after photore-fractive keratectomy and laser in situ keratomileusis. J Cataract Refract Surg. 2001;27(11):1840-1846.
41. King WJ, Comer RM, Hudde T, Larkin DF, George AJ. Cytokine and chemokine expression kinetics after corneal transplantation. Transplantation. 2000;70(8):1225-1233.
42. Long Q, Chu R, Zhou X, et al. Correlation between TGF-beta1 in tears and corneal haze following LASEK and epi-LASIK. J Refract Surg. 2006;22(7):708-712.
43. Lee JB, Choe CM, Kim HS, Seo KY, Seong GJ, Kim EK. Comparison of TGF-beta1 in tears following laser subepithelial keratomileusis and photorefractive keratectomy. J Refract Surg. 2002;18(2):130-134.
44. Bustamante M, Tasinato A, Maurer F, et al. Overexpression of a mutant form of TGFBI/BIGH3 induces retinal degeneration in transgenic mice. Mol Vis. 2008;14:1129-1137.
45. Zhang Y, Wen G, Shao G, et al. TGFBI deficiency predisposes mice to spontaneous tumor development. Cancer Res. 2009; 69(1):37-44.